KS Kluetzman, RM Thomas… - Biology of …, 2011 - Soc Study Reprod Kerri S. Kluetzman1,2, Richard M. Thomas1, Cheryl A. Nechamen1, and James A. Dias1,2 1Wadsworth Center, New York State Dept of Health, Albany, NY. 2Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY. ... The Authors have nothing to ... Related articles - All 3 versions
LW Westergaard, PMM Bossuyt… - status and date: …, 2011 - update-software.com This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2011, Issue 2 http://www.thecochranelibrary.com ... Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian ... Cited by 2 - Related articles - View as HTML
MD Sterrenburg, SM Veltman-Verhulst… - Human Reproduction …, 2011 - ESHRE RESULTS Ten studies (totaling 1952 IVF cycles) were included in the present meta-analysis, comprising patients younger than 39 years with regular menstrual cycle, normal basal FSH levels and two normal ovaries. Comparison was made between studies using ... Cited by 1 - Related articles - All 6 versions
LW Westergaard, PM Bossuyt… - … of systematic reviews …, 2011 - ncbi.nlm.nih.gov BACKGROUND: hMG and recombinant FSH, have both been used successfully for controlled ovarian hyperstimulation in in vitro fertilization and embryo transfer (IVF-ET). OBJECTIVES: To compare the effectiveness of hMG with rFSH in ovarian stimulation protocols in IVF or ... All 2 versions
S Lie Fong, I Schipper, FH de Jong… - Fertility and Sterility, 2011 - Elsevier To describe changes of anti-Müllerian hormone (AMH) and inhibin B during low-dose gonadotropin ovulation induction (OI) treatment in women with polycystic ovary syndrome (PCOS), and thus disturbed selection of the dominant follicle. ... Women with PCOS (n = 48) and normo- ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
